Yazar "Eken, E." için listeleme
-
What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?
Akleylek, C.; Gür, S.G.; Sever, İH.; Koçulu Demir, S.; Çevik, E.; Eken, E.; Yılmaz, N. (NLM (Medline), 2022)OBJECTIVE: Recommendations for the treatment of cytokine release syndrome/macrophage activation syndrome (MAS) associated with coronavirus disease-2019 (COVID-19) are still of poor quality. IL-6 is an important therapeutic ...